KF
Kevin Feeley (CHIEF FINANCIAL OFFICER) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in GeneDx Holdings Corp. (WGS). The largest single filing was $486K of WGS (6,187 sh across 3 lots, as filed), executed Mar 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.4M
shares × price, as filed
Last traded
Sep 16
Filed Sep 18
Median ADV $82.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $11.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 12 months
Most traded names
WGSRecent filings
WGSSALE
GeneDx Holdings Corp.
View filing →
$805K8,418 sh × $95.66
Exec Mar 26 2025
Filed Mar 28 2025 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $363K
3,749 sh × $96.71
Exec Mar 17 2025
Filed Mar 17 2025 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $3.2M
34,606 sh across 3 lots
Exec Jan 7 2025
Filed Jan 10 2025 · 5:30 PM ET † WGSSALE GeneDx Holdings Corp. View filing → $286K
3,728 sh × $76.75
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $1.5M
19,344 sh across 5 lots
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET